Phreesia, Inc.

https://www.phreesia.com

Phreesia, Inc. is a software as a service (SaaS) company that provides an integrated platform encompassing software, payments, and patient engagement solutions for healthcare organizations. Founded in 2005, the company's mission is to simplify healthcare experiences daily and foster active patient participation in their care. Phreesia's headquarters are located in Wilmington, Delaware, U.S..

The company offers a comprehensive suite of applications designed to automate and manage the patient intake process. Key offerings include digital registration, insurance verification, clinical screening, consent form management, and point-of-service payment solutions. Phreesia's platform integrates into existing provider workflows and patient interactions, serving a diverse client base that includes ambulatory practices, health systems, hospitals, and life sciences companies. Additional services extend to appointment scheduling, patient communication, telehealth integration, and revenue cycle management.

Phreesia became a publicly traded company on the New York Stock Exchange (NYSE: PHR) in July 2019. Chaim Indig, a co-founder, serves as the Chief Executive Officer, having been appointed in January 2005. Evan Roberts, also a co-founder, is the President of Provider Solutions. The company has expanded its capabilities through strategic acquisitions, including QueueDr and Insignia Health in 2021, Access eForms in August 2023, and AccessOne in September 2025. In March 2026, Phreesia announced the refinancing of a bridge loan with a new $275 million revolving credit facility, and is scheduled to release its fiscal first quarter 2027 financial results on May 27, 2026. In 2025, Phreesia facilitated over 180 million patient visits, accounting for approximately one in six visits across the United States.

Latest updates

Phreesia Gains Recognition in Revenue Cycle Management Landscape

Event summary

  • Phreesia has been named to Becker’s Hospital Review’s 2026 list of ‘Revenue Cycle Management Companies to Know’.
  • The company’s platform digitizes patient intake and payment workflows, aiming to improve collections and reduce administrative costs.
  • Phreesia processed over 180 million patient visits in 2025, representing approximately 1 in 6 visits across the U.S.
  • CEO Chaim Indig highlighted the company’s focus on connecting intake and payments to accelerate cash flow and simplify workflows.

The big picture

The recognition from Becker’s underscores the growing importance of digital solutions in addressing the complexities of healthcare revenue cycles. With over 180 million patient visits processed annually, Phreesia occupies a significant position within the market, but faces increasing pressure to demonstrate continued value and innovation. The company's success hinges on its ability to navigate evolving regulatory landscapes and maintain its competitive edge in a rapidly consolidating market.

What we're watching

Market Adoption
The continued adoption of digital patient intake and payment solutions by healthcare providers will be crucial for Phreesia’s growth, as resistance to change and integration challenges remain potential hurdles.
Competitive Pressure
Increased competition within the revenue cycle management space may compress margins and necessitate ongoing innovation to maintain Phreesia’s market position.
Regulatory Scrutiny
Evolving regulations surrounding patient data privacy and payment processing could impact Phreesia’s operational costs and require adjustments to its platform.

MediFind Gains Digital Medicine Society Seal, Bolstering Trust in Provider Directories

Event summary

  • MediFind, a provider directory owned by Phreesia, received the Digital Medicine Society (DiMe) Seal on April 9, 2026.
  • The DiMe Seal assesses digital health platforms based on clinical evidence, privacy/security, and usability.
  • Phreesia acquired MediFind in July 2023.
  • MediFind utilizes data science and AI to connect patients with specialists, particularly for rare and chronic conditions.

The big picture

The DiMe Seal represents a growing emphasis on transparency and validation within the digital health sector, driven by increasing patient scrutiny and regulatory considerations. As online healthcare resources proliferate, independent verification mechanisms like the DiMe Seal are becoming crucial for establishing credibility and attracting users. Phreesia’s acquisition of MediFind and its subsequent validation underscores the importance of data-driven solutions in navigating the complexities of patient care and building trust in digital health tools.

What we're watching

Adoption Rate
The DiMe Seal's impact will depend on its adoption by both patients and providers; widespread recognition is needed for it to meaningfully influence platform selection.
Competitive Response
Other provider directories will likely face pressure to pursue similar certifications, potentially leading to a commoditization of trust signals within the space.
Phreesia Integration
The extent to which MediFind’s data science capabilities are integrated into Phreesia’s broader patient activation platform will determine the overall strategic value of the acquisition.

Phreesia Turns Profit, Boosts Cash Flow Amid Revenue Outlook Cut

Event summary

  • Phreesia achieved positive GAAP net income of $2.3 million and generated $78.8 million in net cash from operating activities in fiscal year 2026.
  • The company's revenue increased 16% year-over-year to $127.1 million in the fourth quarter and 14% to $480.6 million for the full fiscal year.
  • Phreesia completed the acquisition of AccessOne for approximately $164 million, funded through a bridge loan and subsequent refinancing.
  • The company is lowering its revenue outlook for fiscal 2027, citing reduced spending commitments from pharmaceutical manufacturers.

The big picture

Phreesia's turnaround, marked by profitability and strong cash flow generation, is now facing headwinds from macroeconomic uncertainty and shifting industry dynamics. The AccessOne acquisition aimed to expand the company's payment solutions offerings, but the subsequent revenue outlook cut suggests integration challenges or broader market pressures. The company's reliance on pharmaceutical manufacturers for a significant portion of its revenue exposes it to regulatory and commercial risks within the healthcare sector.

What we're watching

Revenue Visibility
The extent to which Phreesia can regain visibility into pharmaceutical manufacturer spending will be a key determinant of future revenue performance, potentially requiring adjustments to forecasting models.
Integration Risk
The success of integrating AccessOne and realizing the anticipated revenue synergies will be critical to offsetting the revenue outlook reduction and justifying the acquisition cost.
AI Efficiency
Whether Phreesia's planned adoption of AI can deliver the promised efficiencies and offset margin pressure remains to be seen, and will be a key indicator of operational resilience.

Phreesia Earns Becker's Recognition, Highlighting Remote Work Model

Event summary

  • Phreesia has been recognized as a Top Place to Work in Healthcare by Becker’s Healthcare for the second time.
  • The recognition highlights Phreesia’s commitment to employee support through benefits, professional development, and workplace practices.
  • Phreesia is a fully remote company, emphasizing connection, growth, and support for its teams.
  • Phreesia processed approximately 170 million patient visits in 2024, representing roughly 1 in 7 visits across the U.S.

The big picture

Phreesia’s recognition underscores the growing importance of employee experience, particularly within the healthcare technology sector. The company’s fully remote model, while offering flexibility and potential cost savings, requires deliberate investment in culture and employee support to avoid the pitfalls of remote work isolation. This award provides a short-term boost to Phreesia’s employer brand, but long-term success hinges on sustaining these practices as the company continues to expand its patient activation platform.

What we're watching

Talent Retention
The ability of Phreesia to sustain this 'Top Workplace' reputation will be crucial as the broader talent market normalizes and competition for skilled employees intensifies.
Remote Work Scalability
How Phreesia manages to maintain a strong culture and employee engagement as it continues to scale its fully remote workforce will be a key indicator of its operational effectiveness.
Competitive Landscape
The recognition may attract talent from competitors, potentially increasing pressure on Phreesia to continually enhance its employee value proposition.

Phreesia's Sesame Street Partnership Wins Point-of-Care Marketing Award

Event summary

  • Phreesia and Sesame Workshop received the Point of Care Excellence Award for their pediatric health and wellness campaign.
  • The collaboration, announced in August 2025, launched a six-part campaign in October 2025.
  • Early results indicate 64% of parents find the Sesame Street content helpful, and 91% find it easy to understand.
  • Phreesia enabled approximately 170 million patient visits in 2024, representing 1 in 7 visits across the U.S.

The big picture

Phreesia's partnership with Sesame Workshop represents a growing trend of leveraging entertainment and beloved characters to improve patient engagement and health outcomes. The collaboration's focus on pediatric care addresses a critical need for accessible and engaging health information for families, and the scale of Phreesia’s platform (170 million visits annually) provides a significant distribution channel for Sesame Workshop's content. This approach could set a precedent for other healthcare technology companies seeking to enhance patient experience and drive adherence through non-traditional means.

What we're watching

Campaign Scalability
The success of this campaign hinges on Phreesia’s ability to effectively integrate Sesame Workshop’s content across its platform and maintain high engagement rates as the collaboration expands.
Content ROI
Whether the increased patient engagement and adherence translate into tangible financial benefits for Phreesia and its healthcare provider clients remains to be seen.
Competitive Response
Other patient intake and engagement platforms will likely observe this partnership and may seek similar collaborations to differentiate their offerings, intensifying competition in the space.

Phreesia Secures $275M Credit Facility, Repays Bridge Loan

Event summary

  • Phreesia refinanced a $110 million bridge loan used to fund the AccessOne Acquisition.
  • The company secured a new $275 million senior secured revolving credit facility from Capital One.
  • Approximately $92.2 million was drawn from the new facility to repay the bridge loan.
  • Phreesia simultaneously terminated its existing $50 million asset-based revolving credit facility.

The big picture

Phreesia's refinancing demonstrates a shift from short-term bridge financing to a more stable, long-term capital structure following the AccessOne acquisition. This move provides the company with greater financial flexibility to pursue growth initiatives, but also introduces the ongoing responsibility of managing a larger debt load. The deal highlights the continued appetite for lending to healthcare technology companies, particularly those focused on patient engagement and digital health solutions.

What we're watching

Debt Profile
The company's ability to maintain favorable borrowing terms will depend on continued operational performance and integration of AccessOne.
Capital Allocation
How Phreesia utilizes the remaining $182.8 million in the revolving credit facility will signal its strategic priorities, particularly regarding acquisitions or capital expenditures.
Integration Risk
The success of the AccessOne acquisition remains a key factor; any integration challenges could impact Phreesia's financial performance and ability to meet debt obligations.

Phreesia Legal Chief's Recognition Highlights Digital Contract Shift

Event summary

  • Tiffany McGee, Assistant General Counsel, Commercial Contracts at Phreesia, has been recognized as a Top Woman Leader in Software by The Software Report.
  • This marks the eighth consecutive year a Phreesia female leader has received this recognition.
  • McGee led Phreesia’s transition to fully digital contracting, reportedly shortening deal cycles and improving close rates.
  • Phreesia processed approximately 170 million patient visits in 2024, representing roughly 1 in 7 visits across the U.S.
  • Previous awardees from Phreesia include Allison Hoffman, Amy VanDuyn, and Sally Thayer.

The big picture

Phreesia's focus on digital patient engagement and the recognition of its legal leadership underscore the growing importance of technology in streamlining healthcare operations and improving patient outcomes. The shift to digital contracting reflects a broader trend among software companies seeking to accelerate deal cycles and reduce administrative overhead. McGee’s role in navigating compliance and security considerations highlights the increasing legal complexity inherent in managing sensitive patient data.

What we're watching

Contract Efficiency
The quantifiable impact of Phreesia’s digital contracting initiative on revenue and operational efficiency warrants further scrutiny, particularly as the company scales its platform.
Talent Retention
Continued recognition of female leadership may bolster Phreesia’s ability to retain key talent, a critical factor in a competitive market for specialized legal and product management expertise.
Regulatory Landscape
The increasing complexity of healthcare data privacy and security regulations will likely place continued pressure on Phreesia’s legal team, requiring ongoing adaptation and expertise.

Phreesia Launches ProviderConnect, Targeting Clinician Engagement Market

Event summary

  • Phreesia Network Solutions launched ProviderConnect on March 3, 2026, targeting healthcare provider (HCP) marketers.
  • ProviderConnect aims to deliver relevant information to clinicians based on anticipated patient cases, moving away from broad marketing blasts.
  • The offering leverages Phreesia’s existing PatientConnect platform, which is used by the top 20 pharmaceutical manufacturers.
  • Phreesia processed approximately 170 million patient visits in 2024, representing roughly one in seven visits across the U.S.
  • ProviderConnect utilizes AI trained on data across Phreesia’s product ecosystem, prioritizing patient privacy.

The big picture

Phreesia’s move into HCP marketing represents a strategic expansion beyond its established patient-facing solutions. The shift towards precision marketing in healthcare, driven by data and AI, is gaining momentum as providers seek to optimize patient care and pharmaceutical companies aim for more targeted outreach. ProviderConnect’s success will depend on its ability to integrate seamlessly into clinical workflows and demonstrate a clear return on investment for both marketers and providers.

What we're watching

Market Adoption
The success of ProviderConnect hinges on HCP willingness to adopt a new information delivery method during already constrained appointment times; early adoption rates will be a key indicator of long-term viability.
Privacy Scrutiny
Given the sensitive nature of patient data and the AI-driven approach, ProviderConnect will face ongoing scrutiny regarding data privacy and compliance with evolving healthcare regulations.
Competitive Response
Existing HCP marketing solutions and emerging platforms will likely respond to ProviderConnect’s entry, potentially intensifying competition and impacting Phreesia’s market share.

Phreesia CEO's Recurring Recognition Signals SaaS Stability

Event summary

  • Chaim Indig, CEO and co-founder of Phreesia, has been named to The Software Report’s Top 50 CEOs of 2025.
  • This marks the third time Indig has received this recognition from The Software Report.
  • Phreesia supports over 4,400 healthcare organizations and facilitated approximately 170 million patient visits in 2024.
  • Phreesia was also recently recognized by The Healthcare Technology Report and featured on The Software Report’s Top 50 Software Companies list.

The big picture

Phreesia’s consistent recognition underscores the growing importance of digital patient engagement solutions within the healthcare sector. The awards highlight the company’s established position in a market increasingly driven by value-based care and patient-centricity. While the awards are a positive signal, they also place increased pressure on Indig and the management team to sustain performance and navigate evolving regulatory landscapes.

What we're watching

Reputational Risk
Consistent recognition of Indig’s leadership may create a key-person risk if he were to depart, potentially impacting investor sentiment and stock performance.
Competitive Landscape
The continued success of Phreesia, as highlighted by these awards, will likely draw increased scrutiny and competition from other patient engagement and digital health platforms.
SaaS Valuation
The market’s perception of Phreesia’s valuation will be influenced by the company’s ability to maintain growth and profitability in a potentially challenging regulatory environment for digital health tools.

Phreesia Breaks into Top 10 of The Software Report’s 2025 Rankings

Event summary

  • Phrees/ia, Inc. was named to The Software Report’s 'Top 50 Software Companies of 2025' list.
  • This marks the company's fourth consecutive year on the list and its first time ranking in the Top 10.
  • The company introduced Phreesia VoiceAI, a conversational automation tool, in 2025.
  • Phreesia enabled approximately 170 million patient visits in 2024, representing 1 in 7 U.S. healthcare visits.

The big picture

Phreesia's ascent into the Top 10 of The Software Report's rankings reflects a's broader shift toward automating the administrative burden in healthcare. The integration of VoiceAI suggests a strategic move to expand its footprint beyond simple intake to include more complex, conversational interaction layers within the patient journey.

What we're watching

AI Integration Efficacy
The extent to which Phreesia VoiceAI adoption scales across its existing patient base will determine its impact on operational efficiency.
Market Penetration
the pace at which Phreesia maintains its 1-in-7 U.S. healthcare visit coverage to defend against emerging niche competitors.
Execution Risk
Whether Phreesia can sustain its upward trajectory in industry rankings and product innovation through successful deployment of new automation technologies.
CID: 261